Yonhap Infomax NewsMay 19, 2025
ImmuneOncia, Yuhan Corporation's immune-oncology subsidiary, lists on KOSDAQ, aiming for growth through technology transfers and clinical advancements in cancer treatments.
#YonhapInfomax #ImmuneOncia #YuhanCorporation #KOSDAQListing #ImmuneCancerDrugs #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63799
Yuhan Corporation's Subsidiary ImmuneOncia Lists on KOSDAQ - 'Growth Through Technology Transfer'

ImmuneOncia, Yuhan Corporation's immune-oncology subsidiary, lists on KOSDAQ, aiming for growth through technology transfers and clinical advancements in cancer treatments.

Yonhap Infomax